EOLO Pharma is a clinical research company. It focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases (e.g. type II diabetes, autoimmune, metabolic syndrome, hypertension, atherosclerosis, etc.)
Eolo Pharma total Funding
Eolo Pharma latest funding size
Time since last funding
|a year ago|
Eolo Pharma investors
|CITES, Ficus Capital|
When was Eolo Pharma founded?
Eolo Pharma was founded in 2017.
Who are Eolo Pharma competitors?
Competitors of Eolo Pharma include NovaLead Pharma, Aepodia and GSK.
Receive alerts for 300+ data fields across thousands of companies